Trial Profile

Metabolism and Pharmacokinetics of BI 425809 After Administration of BI 425809 (C-14) as Oral Solution in Healthy Male Volunteers

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 25 Sep 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Iclepertin (Primary)
Indications Cognition disorders
Focus Pharmacokinetics
Sponsors Boehringer Ingelheim

Most Recent Events

22 Dec 2021 Results determining the mass balance, distribution, metabolism, and excretion of BI 425809 published in the Clinical Drug Investigation
16 Nov 2018 Status changed from active, no longer recruiting to completed.
24 Oct 2018 Planned End Date changed from 3 Dec 2018 to 19 Nov 2018.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com